Protease inhibitors

BMS 150 mg 3624 Pill - blue capsule-shape, 19mm

Generic Name: atazanavir

Pill with imprint BMS 150 mg 3624 is Blue, Capsule-shape and has been identified as Reyataz 150 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 150 mg 3624-150 mg-Blue-Capsule-shape
Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 150 mg 3624-150 mg-Blue-Capsule-shape
Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 150 mg 3624-150 mg-Blue-Capsule-shape
Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 150 mg 3624-150 mg-Blue-Capsule-shape
Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 150 mg 3624-150 mg-Blue-Capsule-shape

Reyataz
Generic Name: atazanavir [ a-ta-zan-a-vir ]
Imprint: BMS 150 mg 3624
Strength: 150 mg
Color: Blue
Size: 19.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Protease inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Lactose monohydrate, Magnesium stearate, FD&C Blue No. 2, Titanium dioxide, Ferric oxide red, Ferric oxide yellow, Isopropyl alcohol, Ammonia, Propylene glycol, Butyl alcohol, Alcohol, Ferrosoferric oxide, Shellac,
Latest News
Related Drugs